GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
ANDREW SHARPE,ANDREW SHARPE,ANTHONY WILLIAM JAMES COOPER,ANTHONY WILLIAM JAMES COOPER,ARNELLE LE GALL,ARNELLE LE GALL,EDWARD PAUL CANNONS,EDWARD PAUL CANNONS,GEMMA VICTORIA WHITE,GEMMA VICTORIA WHITE
申请号：
BR112018016396
公开号：
BR112018016396A2
申请日:
2017.02.10
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): (I) and the salts thereof.The compounds of the invention are inhibitors of kinase activity, in particular the activity of PI3 kinase.a invenção está direcionada a certos novos compostos. especificamente, a invenção está direcionada a compostos da fórmula (i): (i) e sais dos mesmos. os compostos da invenção são inibidores da atividade da cinase, em particular da atividade da pi3 cinase.
